CURCUMIN: THE INDIAN SOLID GOLD

P1: OTE/SPH P2: OTE
SVNY332-Aggarwal December 22, 2006 16:34
16 AGGARWAL ET AL.
39. H. P. Ammon, M. I. Anazodo, H. Safayhi, B. N. Dhawan, and R. C. Srimal, Curcumin:
A potent inhibitor of leukotriene B4 formation in rat peritoneal polymorphonuclear
neutrophils (PMNL). Planta Med 58, 226 (1992).
40. Y. Fujiyama-Fujiwara, R. Umeda, and O. Igarashi, Effects of sesamin and curcumin
on delta 5-desaturation and chain elongation of polyunsaturated fatty acid metabolism
in primary cultured rat hepatocytes. J Nutr Sci Vitaminol (Tokyo) 38, 353–363 (1992).
41. R. Srivastava, Inhibition of neutrophil response by curcumin. Agents Actions 28, 298–
303 (1989).
42. H. P. Ammon, H. Safayhi, T. Mack, and J. Sabieraj, Mechanism of antiinflammatory
actions of curcumine and boswellic acids. J Ethnopharmacol 38, 113–119 (1993).
43. A. C. Reddy and B. R. Lokesh, Studies on anti-inflammatory activity of spice principles
and dietary n-3 polyunsaturated fatty acids on carrageenan-induced inflammation in
rats. Ann Nutr Metab 38, 349–358 (1994).
44. B. Joe and B. R. Lokesh, Effect of curcumin and capsaicin on arachidonic acid
metabolism and lysosomal enzyme secretion by rat peritoneal macrophages. Lipids
32, 1173–1180 (1997).
45. Y. X. Xu, K. R. Pindolia, N. Janakiraman, C. J. Noth, R. A. Chapman, and S. C.
Gautam, Curcumin, a compound with anti-inflammatory and anti-oxidant properties,
down-regulates chemokine expression in bone marrow stromal cells. Exp Hematol 25,
413–422 (1997).
46. B. Joe and B. R. Lokesh, Dietary n-3 fatty acids, curcumin and capsaicin lower the
release of lysosomal enzymes and eicosanoids in rat peritoneal macrophages. Mol
Cell Biochem 203, 153–161 (2000).
47. E. A. Jones, A. Shahed, and D. A. Shoskes, Modulation of apoptotic and inflammatory
genes by bioflavonoids and angiotensin II inhibition in ureteral obstruction. Urology
56, 346–351 (2000).
48. M. Banerjee, L. M. Tripathi, V. M. Srivastava, A. Puri, and R. Shukla, Modulation of
inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation
in rat. Immunopharmacol Immunotoxicol 25, 213–224 (2003).
49. R. C. Lantz, G. J. Chen, A. M. Solyom, S. D. Jolad, and B. N. Timmermann, The
effect of turmeric extracts on inflammatory mediator production. Phytomedicine 12,
445–452 (2005).
50. S. Singh and B. B. Aggarwal, Activation of transcription factor NF-kappa B is suppressed
by curcumin (diferuloylmethane) [corrected]. J Biol Chem 270, 24,995–
25,000 (1995).
51. A. Bierhaus, Y. Zhang, P. Quehenberger, T. Luther, M. Haase, M. Muller, N. Mackman,
R. Ziegler, and P. P. Nawroth, The dietary pigment curcumin reduces endothelial tissue
factor gene expression by inhibiting binding of AP-1 to the DNA and activation of
NF-kappa B. Thromb Haemost 77, 772–782 (1997).
52. A. Munzenmaier, C. Lange, E. Glocker, A. Covacci, A. Moran, S. Bereswill, P. A.
Baeuerle, M. Kist, and H. L. Pahl, A secreted/shed product of Helicobacter pylori activates
transcription factor nuclear factor-kappa B. J Immunol 159, 6140–6147 (1997).
53. U. R. Pendurthi, J. T. Williams, and L. V. Rao, Inhibition of tissue factor gene activation
in cultured endothelial cells by curcumin. Suppression of activation of transcription
factors Egr-1, AP-1, and NF-kappa B. Arterioscler Thromb Vasc Biol 17, 3406–3413
(1997).
54. Y. X. Xu, K. R. Pindolia, N. Janakiraman, R. A. Chapman, and S. C. Gautam, Curcumin
inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity
in bone marrow stromal cells. Hematopathol Mol Hematol 11, 49–62 (1997).